Characterization of breakthrough hemolysis events observed in the phase III randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria

Erstveröffentlichung
2021Authors
Brodsky, Robert A.
de latour, Regis Peffault
Rottinghaus, Scott T.
Röth, Alexander
Risitano, Antonio M.
Wissenschaftlicher Artikel
Published in
Haematologica ; 106 (2021), 1. - S. 230-237. - ISSN 0390-6078
Link to publication
https://dx.doi.org/10.3324/haematol.2019.236877Institutions
UKU. Institut für TransfusionsmedizinSubject headings
[Free subject headings]: SERUM LACTATE-DEHYDROGENASE | LONG-TERM SAFETY | DISEASE | THROMBOSIS | PREGNANCY | RISK[DDC subject group]: DDC 610 / Medicine & health